SARS CoV 2 Infection Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
H
Recruiting
  • COVID-19
  • Sars-CoV-2 Infection
  • CoronaVac
  • Ankara, Turkey Region, Turkey
  • +40 more
2021-10-14
Oct 14, 2021
O
Completed
  • Covid19
  • +2 more
  • Rayaldee 30Mcg Extended-Release (ER) Capsule
  • Placebo
  • San Francisco, California
  • +9 more
2021-10-14
Oct 14, 2021
U
Completed
  • SARS-CoV-2 Infection
  • COVID-19
  • Lockdown and other social distancing measures
  • Temuco, Araucanía, Chile
  • +1 more
2021-10-06
Oct 6, 2021
L
Not yet recruiting
  • 2019 Novel Coronavirus Disease
  • +11 more
  • (no location specified)
2021-10-12
Oct 12, 2021
U
Recruiting
  • SARS-Cov-2 Infection
  • Rheumatoid Arthritis
  • Blood sampling
  • Montpellier, France
    CHU Montpellier
2021-10-06
Oct 6, 2021
U
Recruiting
  • SARS-CoV-2 Infection
  • +3 more
    • Seattle, Washington
      University of Washington International Clinical Research Center
    2021-10-08
    Oct 8, 2021
    A
    Recruiting
    • COVID-19
    • SARS-CoV-2 Infection
    • biological sample
    • Paris, France
    • +1 more
    2021-10-11
    Oct 11, 2021
    V
    Recruiting
    • Covid19
    • +4 more
    • Cohort study
    • Nashville, Tennessee
      Vanderbilt_University MC
    2021-10-11
    Oct 11, 2021
    M
    Enrolling by invitation
    • SARS-CoV-2 Infection
    • MT-2766 High dose
    • +2 more
    • Osaka-shi, Osaka, Japan
    • +2 more
    2021-10-07
    Oct 7, 2021
    R
    Recruiting
    • SARS-CoV-2 Infection
    • RP7214 + Standard of care (SOC)
    • Placebo + Standard of care (SOC)
    • Chennai, India
    • +1 more
    2021-10-05
    Oct 5, 2021
    P
    Active, not recruiting
    • COVID-19
    • SARS-CoV-2 Infection
    • Positive for SARS-CoV-2 infection
    • Greenville, South Carolina
      Prisma Health Upstate
    2021-10-04
    Oct 4, 2021
    S
    Recruiting
    • SARS-CoV-2 Infection
    • +2 more
      • Vienna, Austria(AUT), Austria
      • +3 more
      2021-09-27
      Sep 27, 2021
      U
      Active, not recruiting
      • COVID-19
      • +4 more
      • Exposure (not intervention) - SARS-CoV-2 infection
      • Calgary, Alberta, Canada
        University of Calgary/Alberta Children's Hospital
      2021-09-28
      Sep 28, 2021
      B
      Active, not recruiting
      • SARS-CoV-2 Infection
      • COVID-19
      • BNT162b2
      • Anaheim, California
      • +20 more
      2021-09-29
      Sep 29, 2021
      B
      Recruiting
      • SARS-CoV-2 Infection
      • COVID-19
      • BNT162b2
      • Placebo
      • Athens, Alabama
      • +142 more
      2021-09-29
      Sep 29, 2021
      C
      Recruiting
      • Covid19
      • SARS-CoV-2 Infection
      • Osteopathic Manipulative Treatment in addition to Physiotherapy
      • Physiotherapy
      • Rio de Janeiro, RJ, Brazil
        Hospital Municipal de Reabilitação de Engenho de dentro
      2021-09-27
      Sep 27, 2021
      B
      P
      Active, not recruiting
      • Immunocompromised
      • +5 more
      • BNT162b2 (Tozinameran)
      • New York, New York
        Pfizer Inc.
      2021-09-14
      Sep 14, 2021
      U
      Recruiting
      • Sars-CoV-2 Infection
      • +2 more
      • Low-field magnetic resonance imaging
      • Erlangen, Bavaria, Germany
        Department of Pediatrics and Adolescent Medicine
      2021-09-13
      Sep 13, 2021
      U
      Active, not recruiting
      • SARS-CoV-2 Infection
      • 25 µg SpFN_1B-06-PL + ALFQ (QS21 Adjuvant)
      • +2 more
      • Silver Spring, Maryland
        WRAIR Clinical Trials Center
      2021-09-13
      Sep 13, 2021
      U
      Not yet recruiting
      • Covid19
      • SARS-CoV-2 Infection
      • Buccal Swab- Copan flocked swab
      • Standard of Care COVID-19 swab
      • (no location specified)
      2021-09-08
      Sep 8, 2021